Ceftazidime dihydrochloride CAS: 73547-70-3

Atropine Sulfate (CAS 5908-99-6) is a GMP-compliant, high-purity anticholinergic active pharmaceutical ingredient (API). With potent muscarinic receptor blocking activity, it is widely used in antispasmodic, anti-bradycardia, ophthalmic mydriasis and organophosphate poisoning rescue, fully complying with USP/EP/CP pharmacopoeia standards.

Benzgalantamine Gluconate (CAS 1542321-58-3) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a prodrug of galantamine and reversible acetylcholinesterase inhibitor. With low gastrointestinal side effects and proven cognitive-improving efficacy, it is FDA-approved for treating mild-to-moderate Alzheimer's dementia, meeting global pharmaceutical quality standards.

Cilostazol (CAS 73963-72-1) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a selective phosphodiesterase 3 (PDE3) inhibitor with dual antiplatelet and vasodilatory effects. Globally approved for intermittent claudication from peripheral arterial disease, it fully meets USP/EP/CP pharmacopoeia standards.

Dotinurad (CAS 1285572-51-1) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a highly selective URAT1 inhibitor that suppresses renal uric acid reabsorption. Approved in Japan for hyperuricemia and gout treatment, it delivers potent urate-lowering efficacy with favorable safety, fully complying with ICH and global pharmacopoeia standards.

Edoxaban (CAS 1229194-11-9) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a selective direct factor Xa inhibitor oral anticoagulant. Globally approved for stroke prevention in non-valvular atrial fibrillation and venous thromboembolism treatment & prevention, it fully meets ICH, USP and EP pharmacopoeia standards.

Galantamine Hydrobromide (CAS 1953-04-4) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a reversible, centrally selective acetylcholinesterase inhibitor. Globally approved for mild-to-moderate Alzheimer's dementia cognitive improvement, it fully meets USP/EP/CP and ICH international quality standards.

Rimegepant Sulfate (CAS 1374024-48-2) is a high-purity, GMP-compliant active pharmaceutical ingredient. As a potent oral CGRP receptor antagonist, it is indicated for both acute treatment and preventive management of migraine in adults. It meets ICH, USP and EP pharmacopoeial standards, suitable for pharmaceutical R&D and commercial tablet formulation production.

Terbinafine Hydrochloride (CAS 78628-80-5) is a high-purity, GMP-compliant allylamine antifungal API. It blocks fungal squalene epoxidase to achieve strong fungicidal activity, mainly used for treating onychomycosis, dermatophytosis and superficial fungal infections. It complies with USP, EP and ICH pharmacopoeial standards, ideal for pharmaceutical formulation manufacturing.

Tranexamic Acid (CAS 1197-18-8) is a high-purity, GMP-compliant antifibrinolytic API. It inhibits plasminogen activation to control excessive bleeding, widely used for surgical hemostasis, menorrhagia, and hemorrhagic disorders. It meets USP, EP and ICH pharmacopoeial standards and is suitable for oral, injectable and topical pharmaceutical formulations.

Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production

Vibegron (CAS 1190389-15-1) is a high-purity, GMP-compliant selective β3-adrenoceptor agonist API. It is clinically used for overactive bladder (OAB) to relieve urinary urgency, frequency and urge incontinence, with good cardiovascular safety profile. It conforms to USP, EP and ICH quality standards, suitable for oral pharmaceutical formulation R&D and commercial manufacturing.